BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10993774)

  • 1. Inconsistent relation of MAPK activation to infarct size reduction by ischemic preconditioning in pigs.
    Behrends M; Schulz R; Post H; Alexandrov A; Belosjorow S; Michel MC; Heusch G
    Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H1111-9. PubMed ID: 10993774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKC-dependent activation of p46/p54 JNKs during ischemic preconditioning in conscious rabbits.
    Ping P; Zhang J; Huang S; Cao X; Tang XL; Li RC; Zheng YT; Qiu Y; Clerk A; Sugden P; Han J; Bolli R
    Am J Physiol; 1999 Nov; 277(5):H1771-85. PubMed ID: 10564130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart.
    Sanada S; Kitakaze M; Papst PJ; Hatanaka K; Asanuma H; Aki T; Shinozaki Y; Ogita H; Node K; Takashima S; Asakura M; Yamada J; Fukushima T; Ogai A; Kuzuya T; Mori H; Terada N; Yoshida K; Hori M
    Circ Res; 2001 Feb; 88(2):175-80. PubMed ID: 11157669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotection by remote ischemic preconditioning exhibits a signaling pattern different from local ischemic preconditioning.
    Heinen NM; Pütz VE; Görgens JI; Huhn R; Grüber Y; Barthuber C; Preckel B; Pannen BH; Bauer I
    Shock; 2011 Jul; 36(1):45-53. PubMed ID: 21478813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of stress-activated protein kinase (p38-MAPK and JNKs) phosphorylation from the protective effect of preconditioning in vivo.
    Iliodromitis EK; Gaitanaki C; Lazou A; Bofilis E; Karavolias GK; Beis I; Kremastinos DT
    J Mol Cell Cardiol; 2002 Aug; 34(8):1019-28. PubMed ID: 12234771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK.
    Nakano A; Baines CP; Kim SO; Pelech SL; Downey JM; Cohen MV; Critz SD
    Circ Res; 2000 Feb; 86(2):144-51. PubMed ID: 10666409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of the washout period in preconditioning.
    Salie R; Lochner A; Loubser DJ
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28118517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p38 MAP kinase is a mediator of ischemic preconditioning in pigs.
    Schulz R; Belosjorow S; Gres P; Jansen J; Michel MC; Heusch G
    Cardiovasc Res; 2002 Aug; 55(3):690-700. PubMed ID: 12160966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between ischaemic and anisomycin-induced preconditioning: role of p38 MAPK.
    Lochner A; Genade S; Hattingh S; Marais E; Huisamen B; Moolman JA
    Cardiovasc Drugs Ther; 2003 May; 17(3):217-30. PubMed ID: 14574080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress-activated protein kinase phosphorylation during cardioprotection in the ischemic myocardium.
    Fryer RM; Patel HH; Hsu AK; Gross GJ
    Am J Physiol Heart Circ Physiol; 2001 Sep; 281(3):H1184-92. PubMed ID: 11514286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways.
    Heidbreder M; Naumann A; Tempel K; Dominiak P; Dendorfer A
    Cardiovasc Res; 2008 Apr; 78(1):108-15. PubMed ID: 18096574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
    Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart.
    Weinbrenner C; Liu GS; Cohen MV; Downey JM
    J Mol Cell Cardiol; 1997 Sep; 29(9):2383-91. PubMed ID: 9299362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary microembolization does not induce acute preconditioning against infarction in pigs-the role of adenosine.
    Skyschally A; Schulz R; Gres P; Konietzka I; Martin C; Haude M; Erbel R; Heusch G
    Cardiovasc Res; 2004 Aug; 63(2):313-22. PubMed ID: 15249189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.
    Ferrer I; Friguls B; Dalfó E; Planas AM
    Acta Neuropathol; 2003 May; 105(5):425-37. PubMed ID: 12677442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
    Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine A(1) receptor induced delayed preconditioning in rabbits: induction of p38 mitogen-activated protein kinase activation and Hsp27 phosphorylation via a tyrosine kinase- and protein kinase C-dependent mechanism.
    Dana A; Skarli M; Papakrivopoulou J; Yellon DM
    Circ Res; 2000 May; 86(9):989-97. PubMed ID: 10807872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death.
    Barancik M; Htun P; Strohm C; Kilian S; Schaper W
    J Cardiovasc Pharmacol; 2000 Mar; 35(3):474-83. PubMed ID: 10710135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xenon preconditioning differently regulates p44/42 MAPK (ERK 1/2) and p46/54 MAPK (JNK 1/2 and 3) in vivo.
    Weber NC; Stursberg J; Wirthle NM; Toma O; Schlack W; Preckel B
    Br J Anaesth; 2006 Sep; 97(3):298-306. PubMed ID: 16793779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Okadaic acid and anisomycin are protective and stimulate the SAPK/JNK pathway.
    Barancik M; Htun P; Schaper W
    J Cardiovasc Pharmacol; 1999 Aug; 34(2):182-90. PubMed ID: 10445668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.